# Bioreliance Ltd. – FDA Inspection, Mar 21, 2019

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/b50e7b96-afd3-494e-b2cf-716caad515c2
Source feed: FDA_Inspections

> FDA inspection 1088154 of Bioreliance Ltd., March 21, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1088154
- Company Name: Bioreliance Ltd.
- Inspection Date: 2019-03-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1223799 - 2023-11-07
- FDA Inspection 1202973 - 2022-06-30
- FDA Inspection 1066803 - 2017-10-10
- FDA Inspection 976603 - 2016-03-17
- FDA Inspection 890477 - 2014-07-18

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)

Company: https://www.keypedia.com/companies/bioreliance-ltd/0c15a584-09c6-4b3f-bb0e-5ac66b915aa1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d